Sharecare Inc. (SHCR)
NASDAQ: SHCR
· Real-Time Price · USD
1.43
-0.01 (-0.35%)
At close: Oct 21, 2024, 10:00 PM
Sharecare Revenue Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enterprise Revenue | 46.18M | 46.96M | 49.48M | 60.22M | 64.05M | 70.19M | 73.76M | 65.22M | 59.89M | 59.77M | 67.02M | 62.84M |
| Enterprise Revenue Growth | -1.67% | -5.09% | -17.83% | -5.99% | -8.75% | -4.84% | +13.09% | +8.91% | +0.20% | -10.81% | +6.65% | n/a |
| Life Sciences Revenue | 17.41M | 15.47M | 27.59M | 20.13M | 17.11M | 17.13M | 25.16M | 20.68M | 17.53M | 16.22M | 24.66M | 24.11M |
| Life Sciences Revenue Growth | +12.54% | -43.92% | +37.06% | +17.67% | -0.11% | -31.93% | +21.65% | +17.98% | +8.08% | -34.20% | +2.26% | n/a |
| Provider Revenue | 30.68M | 28.43M | 28.2M | 32.98M | 29.19M | 28.97M | 24.34M | 28.71M | 26.4M | 24.72M | n/a | n/a |
| Provider Revenue Growth | +7.91% | +0.80% | -14.49% | +12.97% | +0.75% | +19.04% | -15.23% | +8.75% | +6.82% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 53.27M | 48.47M | 46.83M | 48.8M | 50.33M | 49.47M | 48.94M | 50.58M | 57.65M | 70.51M | 66.89M | 58.8M | 31.24M | 31.06M | 39.26M | 21.74M | 30.65M | 24.92M | 28.86M |
| Selling, General, and Administrative Revenue Growth | +9.92% | +3.49% | -4.04% | -3.04% | +1.74% | +1.08% | -3.25% | -12.25% | -18.24% | +5.40% | +13.77% | +88.20% | +0.58% | -20.88% | +80.59% | -29.07% | +22.98% | -13.64% | n/a |
| Research and Development Revenue | 14.71M | 14.54M | 16.93M | 15.27M | 17.04M | 20.81M | 16.29M | 17.14M | 17.68M | 19.42M | 21.84M | 16.33M | 15.81M | 20.45M | 12.47M | 10.46M | 10.08M | 11.07M | 11.24M |
| Research and Development Revenue Growth | +1.17% | -14.11% | +10.90% | -10.37% | -18.13% | +27.73% | -4.94% | -3.08% | -8.96% | -11.07% | +33.70% | +3.30% | -22.69% | +64.00% | +19.25% | +3.76% | -8.91% | -1.51% | n/a |
| Sales and Marketing Revenue | 13.59M | 13.56M | 13.56M | 13.55M | 14.96M | 15.35M | 15.17M | 12.03M | 14.15M | 14.51M | 15.36M | 12.49M | 12.05M | 11.51M | 9.11M | 6.34M | 8.36M | 9.53M | 9.1M |
| Sales and Marketing Revenue Growth | +0.21% | -0.03% | +0.10% | -9.43% | -2.53% | +1.16% | +26.10% | -15.00% | -2.45% | -5.53% | +22.96% | +3.70% | +4.66% | +26.37% | +43.70% | -24.22% | -12.19% | +4.62% | n/a |